191 related articles for article (PubMed ID: 18533725)
1. Computational anti-AIDS drug design based on the analysis of the specific interactions between immunophilins and the HIV-1 gp120 V3 loop. Application to the FK506-binding protein.
Andrianov AM
J Biomol Struct Dyn; 2008 Aug; 26(1):49-56. PubMed ID: 18533725
[TBL] [Abstract][Full Text] [Related]
2. Immunophilins and HIV-1 V3 loop for structure-based anti-AIDS drug design.
Andrianov AM
J Biomol Struct Dyn; 2009 Feb; 26(4):445-54. PubMed ID: 19108583
[TBL] [Abstract][Full Text] [Related]
3. Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
Andrianov AM; Anishchenko IV
J Biomol Struct Dyn; 2009 Oct; 27(2):179-93. PubMed ID: 19583444
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.
Andrianov AM; Veresov VG
J Biomol Struct Dyn; 2007 Jun; 24(6):597-608. PubMed ID: 17508782
[TBL] [Abstract][Full Text] [Related]
5. Local structural properties of the V3 loop of Thailand HIV-1 isolate.
Andrianov AM
J Biomol Struct Dyn; 2002 Jun; 19(6):973-89. PubMed ID: 12023800
[TBL] [Abstract][Full Text] [Related]
6. Conformational preferences of the HIV-1 principal neutralizing determinant.
Andrianov AM
J Biomol Struct Dyn; 2005 Dec; 23(3):267-82. PubMed ID: 16218754
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
Neurath AR; Strick N; Debnath AK
J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
[TBL] [Abstract][Full Text] [Related]
8. [Conformation of the HIV-1 gp120 V3 loop. Structure functional analysis of the HIV-Haiti viral strain].
Andrianov AM
Tsitologiia; 2006; 48(11):948-57. PubMed ID: 17233480
[TBL] [Abstract][Full Text] [Related]
9. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of the V3 loop of a Thailand HIV isolate.
Gupta G; Anantharamaiah GM; Scott DR; Eldridge JH; Myers G
J Biomol Struct Dyn; 1993 Oct; 11(2):345-66. PubMed ID: 8286061
[TBL] [Abstract][Full Text] [Related]
11. The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood.
Endrich MM; Gehring H
Eur J Biochem; 1998 Mar; 252(3):441-6. PubMed ID: 9546659
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel promising targets for anti-AIDS drug developments by computer modeling: application to the HIV-1 gp120 V3 loop.
Andrianov AM; Anishchenko IV; Tuzikov AV
J Chem Inf Model; 2011 Oct; 51(10):2760-7. PubMed ID: 21888425
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
[TBL] [Abstract][Full Text] [Related]
14. Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120.
Weliky DP; Bennett AE; Zvi A; Anglister J; Steinbach PJ; Tycko R
Nat Struct Biol; 1999 Feb; 6(2):141-5. PubMed ID: 10048925
[TBL] [Abstract][Full Text] [Related]
15. Dynamic NMR studies of ligand-receptor interactions: design and analysis of a rapidly exchanging complex of FKBP-12/FK506 with a 24 kDa calcineurin fragment.
Fejzo J; Lepre CA; Peng JW; Su MS; Thomson JA; Moore JM
Protein Sci; 1996 Sep; 5(9):1917-21. PubMed ID: 8880916
[TBL] [Abstract][Full Text] [Related]
16. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
17. FKBP family proteins: immunophilins with versatile biological functions.
Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
[TBL] [Abstract][Full Text] [Related]
18. Determining the invariant structure elements of the HIV-1 variable V3 loops: insight into the HIV-MN and HIV-Haiti isolates.
Andrianov AM
J Biomol Struct Dyn; 2008 Oct; 26(2):247-54. PubMed ID: 18597546
[TBL] [Abstract][Full Text] [Related]
19. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
[TBL] [Abstract][Full Text] [Related]
20. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]